Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume:6313.4
3.38
-0.04  (-1.17%)
Announcement & Circular
08-18
2015
NOTICE OF BOARD MEETING
08-12
2015
ANNOUNCEMENT - COMPLETION OF PHASE 1 CLINICAL STUDIES OF ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) IN THE U.S.
08-03
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2015
07-06
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2015
07-02
2015
ANNOUNCEMENT - APPROVAL FOR THE COMMENCEMENT OF PHASE 2 AND PHASE 3 CLINICAL TRIALS FOR ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS (LY03005) IN CHINA
06-24
2015
TERMINATION OF MAJOR TRANSACTION REFUND OF DEPOSIT
06-08
2015
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 8 JUNE 2015
06-05
2015
ANNOUNCEMENT - INCREASE IN SHAREHOLDING IN THE COMPANY BY CONTROLLING SHAREHOLDER
06-03
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2015
06-01
2015
DISCLOSEABLE TRANSACTIONS - SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS
46
47
48
49
50